NCT01006161 Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1) Status WITHDRAWN Phase PHASE2
NCT01004432 Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Status COMPLETED Phase PHASE3
NCT01003431 A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN) Status WITHDRAWN Phase PHASE3
NCT01000818 A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054) Status COMPLETED Phase PHASE1
NCT01000155 Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease Status TERMINATED Phase PHASE2
NCT00999336 A Study to Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT00998985 A Study of Grazoprevir (MK-5172) in Hepatitis C-Infected Male Participants (MK-5172-004) Status COMPLETED Phase PHASE1
NCT00998725 Combined Oral Contraceptive (COC) Antiretroviral (ARV) Pharmacokinetics (PK) and Pharmacodynamics (PD) in Malawi Status WITHDRAWN Phase N/A
NCT00996801 MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) Status COMPLETED Phase PHASE2
NCT00996567 A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. Status COMPLETED Phase PHASE2
NCT00993187 Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) Status COMPLETED Phase PHASE4
NCT00990821 A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) Status COMPLETED Phase PHASE1
NCT00990808 The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) Status COMPLETED Phase PHASE1
NCT00989079 A Single Escalating Dose Study Of Ertugliflozin (PF-04971729, MK-8835) Under Fed and Fasted Conditons In Healthy Volunteers (MK-8835-036) Status COMPLETED Phase PHASE1
NCT00988884 A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005) Status COMPLETED Phase PHASE3
NCT00988832 An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066) Status COMPLETED Phase N/A
NCT00988728 Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN) Status WITHDRAWN Phase PHASE2
NCT00988520 Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977) Status COMPLETED Phase PHASE3